Haoming Mai

Pan-Cancer Analysis Identified C1ORF112 as a Potential Biomarker for Multiple Tumor Types

Jiaxuan Chen, Haoming Mai, Haitao Chen et al. · Frontiers in Molecular Biosciences · 2021 · 31 citations · Full text

Medicine, Molecular Biology, Oncology +17

<scp>TRIM26</scp> inhibits hepatitis B virus replication by promoting <scp>HBx</scp> degradation and <i>TRIM26</i> genetic polymorphism predicts <scp>PegIFNα</scp> treatment response of <scp>HBeAg‐positive</scp> chronic hepatitis B Patients

Mengqi Luo, Jia Hou, Haoming Mai et al. · Alimentary Pharmacology & Therapeutics · 2022 · 20 citations

Life Sciences, Genetics, Molecular Biology +15

Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese

Haoming Mai, Jiaxuan Chen, Haitao Chen et al. · Journal of Hepatocellular Carcinoma · 2021 · 17 citations · Full text

Life Sciences, Genetics, Immunology +17

Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds

Haoming Mai, Haisheng Xie, Mengqi Luo et al. · Cancers · 2022 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +17

A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis

Haoming Mai, Haisheng Xie, Jia Hou et al. · Journal of Hepatocellular Carcinoma · 2021 · 12 citations · Full text

Medicine, Genetics, Molecular Genetics +17